Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy.

[1]  Monica Morrow,et al.  Locoregional treatment of primary breast cancer , 2010, Cancer.

[2]  A. Taghian,et al.  Prognostic factors for local control after breast conservation: does margin status still matter? , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Hart,et al.  Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Kurosumi,et al.  Ipsilateral breast tumor relapse after breast conserving surgery in women with breast cancer. , 2009, Breast.

[5]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[6]  I. Olivotto,et al.  Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. , 2009, International journal of radiation oncology, biology, physics.

[7]  Krystyna Kiel,et al.  Breast cancer. Clinical practice guidelines in oncology. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

[8]  E. van Limbergen,et al.  Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  K. Fradette,et al.  The impact of margin status on local recurrence following breast conserving therapy for invasive carcinoma in Manitoba , 2008, Journal of surgical oncology.

[10]  M. Morrow.  Margins in breast-conserving therapy: have we lost sight of the big picture? , 2008, Expert review of anticancer therapy.

[11]  M. J. van de Vijver,et al.  Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up. , 2008, International journal of radiation oncology, biology, physics.

[12]  Simone Mocellin,et al.  Role of resection margins in patients treated with breast conservation surgery , 2008, Cancer.

[13]  M. Andersson,et al.  Breast conserving treatment in Denmark, 1989–1998. A nationwide population-based study of the Danish Breast Cancer Co-operative Group. , 2008, Acta oncologica.

[14]  C. Wells,et al.  The role of radiotherapy in treating small early invasive breast cancer. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  Alberto Luini,et al.  The surgical margin status after breast-conserving surgery: discussion of an open issue , 2008, Breast Cancer Research and Treatment.

[16]  A. Lee,et al.  Clinical outcome of breast conservation therapy for breast cancer in Hong Kong: prognostic impact of ipsilateral breast tumor recurrence and 2005 St. Gallen risk categories. , 2007, International journal of radiation oncology, biology, physics.

[17]  A. Vincent-Salomon,et al.  Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  J. Forbes,et al.  Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  David Cameron,et al.  2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial , 2007, The Lancet.

[20]  S. Singletary,et al.  Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy , 2007, Annals of Surgical Oncology.

[21]  L. Stitt,et al.  The effect of timing of radiotherapy after breast-conserving surgery in patients with positive or close resection margins, young age, and node-negative disease, with long term follow-up. , 2006, International journal of radiation oncology, biology, physics.

[22]  R. Mansel,et al.  Consensus conference on breast conservation. , 2006, Journal of the American College of Surgeons.

[23]  Robert Shenk,et al.  Breast Conservation Surgery Achieving ≥ 2 mm Tumor‐Free Margins Results in Decreased Local‐Regional Recurrence Rates , 2006, The breast journal.

[24]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[25]  M. Izuo,et al.  The general rules for clinical and pathological recording of breast cancer , 1989, The Japanese journal of surgery.

[26]  Greg Yothers,et al.  Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. , 2005, The New England journal of medicine.

[27]  S. Singletary,et al.  Improving local control with breast‐conserving therapy , 2005, Cancer.

[28]  Saveli Goldberg,et al.  Current Perceptions Regarding Surgical Margin Status After Breast-Conserving Therapy: Results of a Survey , 2005, Annals of surgery.

[29]  J. Bellon,et al.  Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  H. Kuerer,et al.  Advances in breast conservation therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  M. Hiraoka,et al.  Treatment outcome of breast-conserving therapy in patients with positive or close resection margins: Japanese multi institute survey for radiation dose effect , 2005, Breast cancer.

[32]  F. Vicini,et al.  Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast‐conserving therapy at a single institution , 2004, Cancer.

[33]  B. Goh,et al.  Eighteen‐year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy , 2004, Cancer.

[34]  P. Lønning,et al.  Cognitive ability in childhood and cognitive decline in mid-life: longitudinal birth cohort study , 2003, BMJ : British Medical Journal.

[35]  D. Schultz,et al.  Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience. , 2004, International journal of radiation oncology, biology, physics.

[36]  S. Jeffrey,et al.  Predictors of reexcision findings and recurrence after breast conservation. , 2003, International journal of radiation oncology, biology, physics.

[37]  C. Perez.  Conservation Therapy in T1‐T2 Breast Cancer: Past, Current Issues, and Future Challenges and Opportunities , 2003, Cancer journal.

[38]  S. Burgess.  “Users’ Guide to the Medical Literature - A Manual for Evidence Based Clinical Practice”. Edited by Gordon Guyatt and Drummond Rennie, 2002, AMA Press, Chicago, 706 pages , 2003 .

[39]  S. Haga,et al.  Outcome of breast-conserving therapy in the Tokyo women’s medical university breast cancer society experience , 2003, Breast cancer.

[40]  F. Vicini,et al.  Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy. A clinicopathologic study of 607 neoplasms from 583 patients. , 2003, American journal of clinical pathology.

[41]  S. Steinberg,et al.  Eighteen‐year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy , 2003, Cancer.

[42]  L. Price,et al.  Long‐term follow‐up of a prospective policy of margin‐directed radiation dose escalation in breast‐conserving therapy , 2003, Cancer.

[43]  B. Rajan,et al.  Clinicopathological significance of tissue homeostasis in Indian breast cancer , 2003, Breast cancer.

[44]  S. Singletary.  Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. , 2002, American journal of surgery.

[45]  Umberto Veronesi,et al.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. , 2002, The New England journal of medicine.

[46]  B. E. F. Isher,et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002 .

[47]  A. Hanlon,et al.  Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  T. Nakajima,et al.  Breast-conserving surgery following radiation therapy of 50 Gy in stages I and II carcinoma of the breast: the experience at one institute in Japan. , 2002, Oncology reports.

[49]  S. Singletary,et al.  Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma , 2002, CA: a cancer journal for clinicians.

[50]  D. Heron,et al.  Influence of radiation dose on positive surgical margins in women undergoing breast conservation therapy. , 2002, International journal of radiation oncology, biology, physics.

[51]  Gordon H. Guyatt,et al.  Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice; Users' Guides to the Medical Literature: Essentials of Evidence-Based Clinical Practice , 2003, BMJ : British Medical Journal.

[52]  Douglas G. Altman,et al.  Systematic Reviews in Health Care: Meta-Analysis in Context: Second Edition , 2008 .

[53]  Douglas G Altman,et al.  Systematic reviews of evaluations of prognostic variables , 2001, BMJ : British Medical Journal.

[54]  J. Peterse,et al.  Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  M. Hiraoka,et al.  Results of Breast-Conserving Therapy for Early Stage Breast Cancer: Kyoto University Experiences , 2000, American journal of clinical oncology.

[56]  L Fallowfield,et al.  Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. , 2000, European journal of cancer.

[57]  Richard Sylvester,et al.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. , 2000, Journal of the National Cancer Institute.

[58]  S J Schnitt,et al.  Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  I. Bleiweiss,et al.  Lumpectomy margins, reexcision, and local recurrence of breast cancer. , 2000, American journal of surgery.

[60]  B. Haffty,et al.  Negative margin status improves local control in conservatively managed breast cancer patients. , 2000, The cancer journal from Scientific American.

[61]  A. Hanlon,et al.  Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. , 1999, International journal of radiation oncology, biology, physics.

[62]  D. Schultz,et al.  Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience. , 1999, International journal of radiation oncology, biology, physics.

[63]  E. Touboul,et al.  Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. , 1999, International journal of radiation oncology, biology, physics.

[64]  T. Nakajima,et al.  Surgical margin and breast recurrence after breast-conserving therapy. , 1999, Oncology reports.

[65]  D. Wazer,et al.  Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. , 1998, International journal of radiation oncology, biology, physics.

[66]  A. Schauer,et al.  Eight-year results of a prospective non-randomised study on therapy of small breast cancer. The German Breast Cancer Study Group (GBSG). , 1998, European journal of cancer.

[67]  F. Vicini,et al.  Long term results with breast‐conserving therapy for patients with early stage breast carcinoma in a community hospital setting , 1998, Cancer.

[68]  I. Gage,et al.  Pathologic margin involvement and the risk of recurrence in patients treated with breast‐conserving therapy , 1996 .

[69]  A. Recht,et al.  The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. , 1996, The New England journal of medicine.

[70]  J. Gazet,et al.  The importance of the resection margin in conservative surgery for breast cancer. , 1996, European Journal of Surgical Oncology.

[71]  S. Jeffrey,et al.  The importance of the lumpectomy surgical margin status in long term results of breast conservation , 1995, Cancer.

[72]  J. Peacock,et al.  Importance of margin status in outcome of breast-conserving surgery for carcinoma. , 1994, Surgery.

[73]  S J Schnitt,et al.  The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast‐conserving surgery and radiation therapy , 1994, Cancer.

[74]  A. Hart,et al.  Risk factors in breast-conservation therapy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[75]  G. Guyatt,et al.  Users' guides to the medical literature. , 1993, JAMA.

[76]  H. Mouridsen,et al.  Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. , 1992, Journal of the National Cancer Institute. Monographs.

[77]  D. Schultz,et al.  The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. , 1991, International journal of radiation oncology, biology, physics.

[78]  J. Hendriks,et al.  Histologic multifocality of tis, T1–2 breast carcinomas implications for clinical trials of breast‐conserving surgery , 1985, Cancer.

[79]  M. Lagios.  Multicentricity of breast carcinoma demonstrated by routine correlated serial multicentric breast carcinoma subgross and radiographic examination , 1977, Cancer.